(Q35544018)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510627%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

review article

1 reference

title

Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510627%20AND%20SRC:MED&resulttype=core&format=json

Agnieszka Swiatecka-Urban

19 December 2019

author

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510627%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Agnieszka Swiatecka-Urban

series ordinal

1

1 reference

8 August 2017

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510627%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510627%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510627%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510627%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

699-716

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510627%20AND%20SRC:MED&resulttype=core&format=json

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

19 December 2019

cites work

1 reference

12 December 2020

A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs

1 reference

12 December 2020

Review of transplantation--1996.

1 reference

12 December 2020

Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells

1 reference

12 December 2020

Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation

1 reference

12 December 2020

Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link

1 reference

12 December 2020

Basiliximab versus ATG/ALG induction in pediatric renal transplants: comparison of herpes virus profile and rejection rates

1 reference

12 December 2020

Basiliximab in paediatric liver-transplant recipients

1 reference

12 December 2020

Basiliximab induction improves the outcome of renal transplants in children and adolescents.

1 reference

12 December 2020

Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation

1 reference

12 December 2020

Efficacy and safety of basiliximab in pediatric renal transplantation

1 reference

12 December 2020

Tacrolimus in pediatric renal transplantation

1 reference

12 December 2020

The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998.

1 reference

12 December 2020

Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation

1 reference

12 December 2020

Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group

1 reference

12 December 2020

Perforin and lymphocyte-mediated cytolysis.

1 reference

12 December 2020

Pediatric renal transplantation under FK 506 immunosuppression

1 reference

12 December 2020

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

12 December 2020

Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period

1 reference

12 December 2020

A humanized antibody that binds to the interleukin 2 receptor

1 reference

12 December 2020

Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation

1 reference

12 December 2020

Clinical use of tacrolimus (FK-506) in infants and children with renal transplants

1 reference

12 December 2020

Basiliximab in paediatric liver-transplant recipients

1 reference

12 December 2020

Interleukin-2 receptor antibody-induced alterations of ciclosporin dose requirements in paediatric transplant recipients

1 reference

12 December 2020

Rejection profile of recent pediatric renal transplant recipients compared with historical controls: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

1 reference

12 December 2020

1 reference

12 December 2020

Pediatric renal transplantation under tacrolimus-based immunosuppression

1 reference

12 December 2020

The impact of an acute rejection episode on long-term renal allograft survival (t1/2)

1 reference

12 December 2020

Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506)

1 reference

12 December 2020

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

1 reference

12 December 2020

Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity

1 reference

12 December 2020

Long-term results of cyclosporin A therapy in children

1 reference

12 December 2020

Liver and kidney transplantation in children receiving cyclosporin A and steroids

1 reference

12 December 2020

Granzymes: exogenous proteinases that induce target cell apoptosis.

1 reference

12 December 2020

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

12 December 2020

Human and humanized monoclonal antibodies: preclinical studies and clinical experience

1 reference

12 December 2020

[An attempted kidney transplantation in man: medical and biological aspects]

1 reference

12 December 2020

Immunosuppression in the post-adaptation period

1 reference

12 December 2020

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

12 December 2020

Experience with basiliximab in pediatric renal transplantation

1 reference

12 December 2020

Pediatric kidney transplantation: historic hallmarks and a personal perspective

1 reference

12 December 2020

Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors

1 reference

12 December 2020

A randomized clinical trial of induction therapy with OKT3 in kidney transplantation

1 reference

12 December 2020

Daclizumab rapidly saturates interleukin-2 receptor-alpha (CD25) on lymph node lymphocytes in children

1 reference

12 December 2020

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

1 reference

12 December 2020

Prolonged survival of human-kidney homografts by immunosuppressive drug therapy

1 reference

12 December 2020

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

12 December 2020

Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients

1 reference

12 December 2020

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

12 December 2020

Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes

1 reference

12 December 2020

Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center

1 reference

12 December 2020

A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients

1 reference

12 December 2020

A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations.

1 reference

12 December 2020

Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival

1 reference

12 December 2020

Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation

1 reference

12 December 2020

Cadaveric renal transplantation in children

1 reference

12 December 2020

Overview of clinical trials with new agents

1 reference

12 December 2020

Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group

1 reference

12 December 2020

Anti-interleukin-2 receptor monoclonal antibodies in renal transplantation

1 reference

12 December 2020

Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients

1 reference

12 December 2020

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection

1 reference

12 December 2020

OKT3 first-dose reaction: association with T cell subsets and cytokine release

1 reference

12 December 2020

Mycophenolate mofetil: a report of the consensus panel.

1 reference

12 December 2020

Single centre experience with basiliximab in paediatric renal transplantation

1 reference

12 December 2020

Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.

1 reference

12 December 2020

Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients

1 reference

12 December 2020

Cyclosporine experience in renal transplantation in children

1 reference

12 December 2020

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

1 reference

12 December 2020

Long-term survival of kidney allografts

1 reference

12 December 2020

Renal transplantation in infants and children

1 reference

12 December 2020

Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients

1 reference

12 December 2020

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

12 December 2020

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

12 December 2020

Cyclosporin A in patients receiving renal allografts from cadaver donors

1 reference

12 December 2020

Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups

1 reference

12 December 2020